Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
Collaboration with Regeneron4.71M37.91%
Other4M32.17%
ide-cel ex-U.S. service revenue from Bristol Myers Squibb’s (BMS)2.2M17.70%
Service revenue from December 2021 agreement with Novo Nordisk1.52M12.22%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States100.39M100.00%
